Alliance A051202: A Phase I Trial of Lenalidomide, Rituximab and GS-1101 (Idelalisib) in recurrent follicular lymphoma
      Google Scholar   
Citation:
Hematol Oncol vol 31 (51) 271-278 (abstr 563)
Meeting Instance:
ICML 2013
Year:
2013
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
       
Networks:
 
Study
Alliance-A051202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1
Keywords: